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SUMMARY
Bleomycin is a chemotherapeutic agent used in the
treatment of different tumours. It has several side effects,
including ﬂagellate hyperpigmentation, which is a unique
and a well-documented side effect of bleomycin therapy.
We report a case of a 23-year-old woman with a personal
history of ovarian dysgerminoma, who developed ﬂagellate
hyperpigmentation on trunk after bleomycin therapy.
BACKGROUND
Bleomycin is a chemotherapeutic agent, which has
been used in the treatment of lymphoproliferative
syndromes, squamous cell carcinomas, ovarian
germ cell tumours and testicular tumours.1 2 Most
organs contain a cysteine proteinase, capable of
hydrolysing and inactivating bleomycin, except skin
and lungs.2–4 The cutaneous-mucous side effects
of bleomycin are diverse, including alopecia,
stomatitis, nail changes and hyperpigmentation.2
Hyperpigmentation associated with bleomycin may
be diffuse, patchy or linear.3 5 Flagellate hyperpig-
mentation is a linear or streaked pigmentation,
which is a well-documented side effect of bleo-
mycin therapy with an incidence as high as 20%.1 4
CASE PRESENTATION
A 23-year-old woman presented with ﬂagellate
hyperpigmentation on her trunk. She had a history
of ovarian dysgerminoma, treated with unilateral
salpingo-oophorectomy and adjuvant chemother-
apy. Chemotherapy included 20 mg/m2/day of cis-
platin and 100 mg/m2/day of etoposide
intravenously, on days 1–5. She also received bleo-
mycin, 30 mg intravenously on days 1, 8 and 15.
The cycle was repeated every 3 weeks until three
complete cycles. Within 4 weeks after the treat-
ment, painless, pruritic, ﬂagellate hyperpigmenta-
tion developed on her trunk. At presentation to
our department, 5 months after the last cycle of
chemotherapy, the skin examination revealed
multiple curvilinear brownish hyperpigmented
streaks, scattered profusely throughout her trunk
(ﬁgures 1 and 2). There was no erythema, scaling
or atrophy.
She had no alopecia and no changes in the
appearance of nails or mucosa. She reported having
no respiratory symptoms. On the basis of the
history and examination, the diagnosis of
bleomycin-induced ﬂagellate hyperpigmentation
was performed.
TREATMENT
Low-potency topical steroid was given to be
applied to the pigmentation once a day, during
3 months. The patient was counselled that the
ﬂagellate hyperpigmentation usually fades over a
period of several months after the cessation of
bleomycin.
OUTCOME AND FOLLOW-UP
During 8 months of the follow-up, the hyperpig-
mentation in this patient persisted.
DISCUSSION
Bleomycin is a glycopeptide antibiotic commonly
used for chemical pleurodesis, the treatment of
cutaneous warts and the treatment of several
human cancers, in particular lymphomas, ovarian
and testicular germ cell tumours and squamous cell
carcinomas.1 5
Flagellate hyperpigmentation can appear from
24 h to 9 weeks after the administration of bleo-
mycin.1 6 It usually occurs after cumulative doses
of 100–300 mg; however, it has been reported
after using lower doses, and there is a case
described in the literature of ﬂagellate hyperpig-
mentation after intralesional injection of 14 units
of bleomycin for plantar wart.2
Several hypotheses regarding the cause of hyper-
pigmentation have been proposed, including
induced lesions by scratching the skin and by irrita-
tion from clothing, which permit the drug to leak
out of blood vessels,6 increased levels of melanin
because of various intercellular interactions and
toxic effects of the drug itself.3 6
There is no speciﬁc treatment available for ﬂagel-
late hyperpigmentation.3 5 Pruritus may be treated
with topical steroids and oral antihistamines.3 4
The course of bleomycin-induced ﬂagellate
hyperpigmentation is variable.1 The pigmentation
usually fades over 4 months, once the course of
Figure 1 Multiple curvilinear brownish hyperpigmented
streaks, scattered throughout her upper trunk.
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chemotherapy is complete and bleomycine is discontinued.
Nevertheless, persistence of hyperpigmented streaks for up to
1 year after the treatment has been reported, like this case.3 4
Learning points
▸ Flagellate hyperpigmentation of the skin is a linear or
streaked pigmentation, which is a well-documented side
effect of bleomycin therapy with an incidence as high as
20%.
▸ There is no speciﬁc treatment available for ﬂagellate
hyperpigmentation, but pruritus may be treated with topical
steroids and oral antihistamines.
▸ The pigmentation usually fades over 4 months, after
bleomycine is discontinued. Nevertheless, persistence of
hyperpigmented streaks for up to 1 year after treatment has
been reported, like this case.
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Figure 2 Multiple curvilinear brownish hyperpigmented streaks,
scattered throughout her trunk.
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